Melatonin versus midazolam in the premedication of anxious children attending for elective surgery under general anaesthesia: the MAGIC non-inferiority RCT
Health Technology Assessment · 2025
DOI: 10.3310/cwkf1987 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Health Technology Assessment, 2025. Verfasst von Christopher Deery und 27 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Dentistry, University of Sheffield, Sheffield, UK. Hauptthemen laut MEDLINE: Midazolam, Melatonin, Anxiety, Anesthesia, General. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Technology Assessment programme.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Anxiety in children prior to general anaesthesia is common, with up to half displaying distress. Anxiety and distress may lead to unsuccessful anaesthesia, together with greater postoperative pain, agitation and behavioural changes after surgery including sleep disturbances. Midazolam is the current standard premedication; however, it has adverse effects such as the potential for respiratory suppression and unpredictable effects which may result in agitation rather than anxiolysis. Melatonin is an alternative preoperative anxiolytic; however, previous trials have delivered conflicting results. The aim of this non-inferiority trial was to evaluate the effectiveness of melatonin compared to midazolam in reducing anxiety in children undergoing general anaesthesia.
Methods
We undertook a randomised-controlled, parallel-group, double-blind, non-inferiority trial in 20 United Kingdom National Health Service trusts, with an embedded qualitative study and health economic evaluation. Anxious children having day case elective surgery under general anaesthesia were randomly assigned to either control (standard of care) group: midazolam; or intervention group: melatonin. The primary outcome was preoperative distress (non-inferiority hypothesis) as assessed by modified Yale Preoperative Anxiety Scale Short Form. Secondary outcomes included safety and efficacy objectives. Analyses were by intention to treat, with an additional per-protocol analysis. The sample size of the trial was 624 children.
Results
The trial was stopped early due to recruitment futility. Between 30 July 2019 and 9 November 2022, 110 children were recruited; 55 allocated to midazolam and 55 allocated to melatonin. Pre-planned analyses showed an adjusted mean difference of 13.1 (95% confidence interval 3.7 to 22.4) for the intention-to-treat population and 12.9 (95% confidence interval 3.1 to 22.6) for the per-protocol population, in favour of midazolam. In both analyses, the upper limit of the 95% confidence interval exceeds the predefined margin of 4.3; therefore, melatonin is not non-inferior to midazolam. The lower limit of the 95% confidence intervals excludes zero and thus melatonin is inferior to midazolam; the difference found is considered to be clinically meaningful. Adverse events in the midazolam arm (26%) were slightly higher than melatonin (18%); there were no serious adverse events in either arm. Challenges to recruitment included study-related factors (eligibility criteria and trial design), participant factors (caregiver stress on the day of treatment) and practitioner factors (valuing predictability). In terms of acceptability, preferences of the anaesthetist, patient and caregiver factors and medication side effects profile were influential and suggest the choice of preoperative anxiolytic is more complex than previously described. On average, costs over the 14 days post surgery were lower for those who received melatonin (−£46.20, 95% confidence interval −£166.14 to £66.74) with a mean incremental difference in procedure success of −0.02 (95% confidence interval −0.08 to 0.004), although there was uncertainty around the results.
Conclusion
In children with preoperative anxiety, midazolam is more effective than melatonin at reducing preoperative anxiety prior to general anaesthesia, although the early termination of the trial increases the likelihood of bias.
Limitations
The trial was prematurely terminated due to recruitment futility. Despite this, a clinically meaningful and statistically significant finding was observed about the primary outcome. Future work There remains a need to develop or repurpose another drug with a more favourable side effects profile to midazolam. Funding This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 16/80/08.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical Dentistry, University of Sheffield, Sheffield, UK.
- Sheffield Clinical Trials Research Unit, Sheffield Centre for Health & Related Research, University of Sheffield, Sheffield, UK.
- Sheffield Centre for Health & Related Research, University of Sheffield, Sheffield, UK.
- School of Dentistry, University of Liverpool, Liverpool, UK.
- Dundee Dental Hospital and School, University of Dundee, Dundee, UK.
- University College London Hospitals NHS Foundation Trust, London, UK.
ORCID-Profile: Christopher Deery, Robert Bolt, Diana Papaioannou, Matthew Wilson, Marie Hyslop, Esther Herbert, Nikki Totton, Zoe Marshman, Tracey Young, Jennifer Kettle, Sondos Albadri, Simon Atkins, Katie Biggs, Janet Clarkson, Chris Evans, Laura Flight, Jacqui Gath, Fiona Gilchrist, Kate Hutchence, Nicholas Ireland, Amanda Loban, Amy Norrington, Jaydip Ray, Helen Rodd, Elena Sheldon, Richard Simmonds, Christopher Vernazza
Förderung
- Health Technology Assessment programme
Zitieren
APA
Deery, C., Bolt, R., Papaioannou, D., Wilson, M., Hyslop, M., Herbert, E., Totton, N., Marshman, Z., Young, T., Kettle, J., Albadri, S., Atkins, S., Biggs, K., Clarkson, J., Evans, C., Flight, L., Gath, J., Gilchrist, F., Hutchence, K., …, & Vernazza, C. (2025). Melatonin versus midazolam in the premedication of anxious children attending for elective surgery under general anaesthesia: the MAGIC non-inferiority RCT. Health Technology Assessment. https://doi.org/10.3310/cwkf1987
Vancouver
Deery C, Bolt R, Papaioannou D, Wilson M, Hyslop M, Herbert E, et al. Melatonin versus midazolam in the premedication of anxious children attending for elective surgery under general anaesthesia: the MAGIC non-inferiority RCT. Health Technology Assessment. 2025. doi:10.3310/cwkf1987
BibTeX
@article{Deery2025,
author = {Deery, Christopher and Bolt, Robert and Papaioannou, Diana and Wilson, Matthew and Hyslop, Marie and Herbert, Esther and Totton, Nikki and Marshman, Zoe and Young, Tracey and Kettle, Jennifer and Albadri, Sondos and Atkins, Simon and Biggs, Katie and Clarkson, Janet and Evans, Chris and Flight, Laura and Gath, Jacqui and Gilchrist, Fiona and Hutchence, Kate and Ireland, Nicholas and Loban, Amanda and Norrington, Amy and Paton, Hamish and Ray, Jaydip and Rodd, Helen and Sheldon, Elena and Simmonds, Richard and Vernazza, Christopher},
title = {Melatonin versus midazolam in the premedication of anxious children attending for elective surgery under general anaesthesia: the MAGIC non-inferiority RCT},
journal = {Health Technology Assessment},
year = {2025},
doi = {10.3310/cwkf1987}
}
EUVIMED